After a frontotemporal dementia (FTD) diagnosis, the questions you ask your neurologist, genetic counselor, and care team will shape your treatment plan and how you prepare for the years ahead. The most important first questions focus on which variant of FTD you have—behavioral variant (bvFTD), semantic dementia, or non-fluent primary progressive aphasia (nfvPPA)—because each progresses differently and affects different cognitive domains. For example, someone with semantic dementia may lose the meaning of words while retaining speech fluency, whereas someone with nfvPPA struggles with speech production itself.
Understanding your specific type, the rate of decline doctors expect, and whether genetic testing reveals a mutation (like C9orf72, GRN, or MAPT) should guide every decision that follows. Beyond diagnosis, you need to ask about disease progression timelines, specialist referrals, medication options, clinical trial eligibility, and whether genetic changes run in your family. These conversations are urgent not because FTD progresses overnight, but because early legal planning, advanced directives, and family disclosure require clarity. A person diagnosed at age 50 with bvFTD might have 8 to 10 years before requiring full-time care, but behavioral changes can accelerate work stress or family conflict within months if no support structure is in place.
Table of Contents
- Which Type of FTD Do I Have and How Will It Progress?
- Is There a Genetic Mutation in My Family, and Should My Relatives Be Tested?
- What Specialists Do I Need to See Beyond My Neurologist?
- What Are the Medication Options for FTD, and Can a Clinical Trial Help?
- How Should I Plan Legally and Financially Now?
- What Should I Tell My Employer and Colleagues?
- How Do I Build a Support System Now, Before I Need It Most?
Which Type of FTD Do I Have and How Will It Progress?
Your first detailed question should ask your neurologist to explain your specific ftd variant and what cognitive or behavioral changes typically appear in that type. bvFTD attacks personality, decision-making, and impulse control—patients may become socially withdrawn, make uncharacteristic financial decisions, or lose empathy—while language variants (PPA) primarily affect speech production or word comprehension. This distinction matters because a family member with bvFTD might need behavioral guardrails and close financial oversight earlier than someone with nfvPPA, who might retain personality but lose the ability to communicate clearly. Ask your neurologist what the typical progression looks like month by month and year by year for your variant, and whether you fall into a fast, moderate, or slow progression category.
The answer depends partly on age at diagnosis (younger-onset FTD sometimes progresses more slowly) and whether imaging shows widespread atrophy or focal changes. Be specific: ask what specific abilities or behaviors you should expect to change in the next 6 months, next 2 years, and next 5 years. A neurologist who tells you “everyone is different” without giving you a realistic range is not giving you actionable information. Push for concrete examples.
Is There a Genetic Mutation in My Family, and Should My Relatives Be Tested?
Approximately 25 to 30 percent of FTD cases run in families, and many are caused by mutations in specific genes. Ask your neurologist whether genetic testing is recommended in your case and whether you should see a genetic counselor before taking a test. A positive genetic result doesn’t diagnose your family members—they may carry the mutation and never develop symptoms—but it does change their medical monitoring and life planning. If your mother has a GRN mutation and you inherited it, your siblings have a 50 percent chance of also carrying it.
This conversation involves privacy and difficult family decisions. A genetic counselor can help you understand what results mean and how to discuss them with relatives who may not want to know. One important limitation: genetic testing can take weeks, and the results sometimes raise more questions than they answer. A genetic carrier who develops typical FTD symptoms at 65 might have had decades of uncertainty, and a relative who carries the mutation but dies in a car accident at 50 never knew whether they would have gotten sick. Ask your counselor specifically how they recommend timing conversations with adult children or siblings, and whether you should test them without symptoms.
What Specialists Do I Need to See Beyond My Neurologist?
A neuropsychologist administers detailed cognitive testing to establish a baseline and measure decline over time—these tests are not like a clinic exam but rather a 2 to 4 hour battery of memory, language, attention, and problem-solving tasks. These results help confirm the diagnosis and show which cognitive areas are most affected, guiding your planning. You’ll also benefit from a speech-language pathologist if you have a language variant, a psychiatrist experienced with FTD if behavioral symptoms are severe, and a social worker or care coordinator to help navigate benefits and community services. Some major medical centers run FTD clinics that bring multiple specialists together.
Ask your neurologist for referrals to these specialists now, even if you feel you don’t need them yet. Wait times can be 3 to 6 months, and baseline cognitive testing is most valuable early, before significant decline. A common mistake is waiting until memory or speech problems become severe before seeing a speech therapist or neuropsychologist. By that time, they have fewer tools to offer and limited data for measuring change. If your neurologist doesn’t offer referrals or says they’re not necessary, consider seeking a second opinion at a university hospital or specialized dementia center.
What Are the Medication Options for FTD, and Can a Clinical Trial Help?
Unlike Alzheimer’s disease, where some disease-modifying medications slow decline, FTD has no FDA-approved disease-modifying treatment. Medications address only secondary symptoms: an antidepressant might reduce apathy or emotional blunting, an antipsychotic might reduce behavioral disinhibition, and a stimulant might address fatigue. These are symptom management tools, not treatments for FTD itself. Ask your neurologist which of your current symptoms might respond to medication and what side effects to watch for.
Behavioral variant FTD especially can be unpredictable—a medication that helps one person worsen someone else’s impulsivity. Clinical trials are actively recruiting for FTD, especially for genetic forms. Some trials target specific mutations (GRN, C9orf72, MAPT) and may offer blood-based biomarker tracking or brain imaging to measure disease activity. Ask whether you’re eligible for any active trials and what participation involves—most require regular clinic visits, spinal taps or advanced imaging, and cognitive testing. The tradeoff is that you receive more frequent specialist monitoring and may contribute to research that helps future patients, but you also invest time and potentially confront disease progression data more directly than you might otherwise.
How Should I Plan Legally and Financially Now?
This conversation is not comfortable, but it’s essential. Ask your neurologist for a referral to an elder law attorney or attorney experienced in cognitive decline, and do this before your legal capacity becomes questionable. You need a healthcare power of attorney, a financial power of attorney, an advance directive specifying end-of-life preferences, and a will. Some of these documents are routine; others require specific choices about what medical interventions you do or do not want if you reach advanced dementia.
A critical limitation of legal planning is that capacity decisions are not absolute—you might retain capacity to make some decisions (medical) while losing capacity in others (financial)—and determining capacity requires expert assessment. Some people with FTD remain alert and aware throughout life; others lose insight early, meaning they may not agree with decisions made by their power of attorney. Before this happens, clarify with your attorney and your designees what your preferences are. If you’ve had strong values around independence, living situation, or medical interventions, spell them out now while you’re able to explain the reasoning.
What Should I Tell My Employer and Colleagues?
Disclosure to your workplace is a personal choice, but the timing matters. Early behavioral changes—disinhibition, poor judgment, social withdrawal—may be misinterpreted as attitude problems or performance decline, potentially jeopardizing your job before you choose to leave. Talking to your HR department and a trusted supervisor or mentor early can frame changes in context and may unlock workplace accommodations (flexible hours, modified responsibilities, remote work) that extend your working life.
If your employer has an employee assistance program (EAP), use it; counselors can help you think through disclosure. A specific example: a person with early bvFTD might say something inappropriate in a meeting that would normally result in a reprimand, but if HR understands that disinhibited speech is part of a known diagnosis, they may redirect rather than discipline. However, disclosure can also invite discrimination or reduced opportunities, so get legal guidance before sharing anything formal.
How Do I Build a Support System Now, Before I Need It Most?
Your family, friends, and professional caregivers will bear the burden of your decline. Ask your neurologist for referrals to FTD-specific support groups (many meet online) and to a social worker who can help coordinate care and identify community resources. Some families benefit from working with a geriatric care manager or professional care coordinator even before decline is severe—this person can help plan transitions, hire and train caregivers, and mediate family decisions about living arrangements or medical interventions.
A concrete example: identifying your primary caregiver now and involving them in medical appointments means they understand your diagnosis, treatment plan, and preferences firsthand rather than secondhand. If your adult daughter will eventually manage your care, she should attend neurologist appointments with you and understand your baseline cognition and your expectations. Support groups for people with FTD (not just caregivers) can also be valuable while you’re still able to communicate—many focus on sharing experiences, grieving losses early, and connecting with others facing the same diagnosis. Organizations like the Association for Frontotemporal Degeneration (AFTD) maintain online and in-person resources; ask your neurologist whether your area has a local chapter or support group.
- —
